Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Moroctocog_alfa> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Moroctocog_alfa abstract "Moroctocog alfa (trade name ReFacto) is a recombinant antihemophilic factor genetically engineered from Chinese hamster ovary (CHO) cell line. Chemically it is a glycoprotein. It is manufactured by Genetics Institute, Inc. and used to control and prevent hemorrhagic bleeding and prophylaxis associated with surgery or to reduce the number of spontaneous bleeding episodes in patients with hemophilia A. It is partially a recombinant coagulation factor VIII since it has an amino acid sequence which compares to the 90 + 80 kDa form of factor VIII (BDDrFVIII). It also has posttranslational modifications which are similar to those of the plasma-derived molecule. It can not prevent hemorrhagic bleeding associated with von Willebrand's disease since it is not a von Willebrand factor.".
- Moroctocog_alfa wikiPageID "26474159".
- Moroctocog_alfa wikiPageLength "2328".
- Moroctocog_alfa wikiPageOutDegree "11".
- Moroctocog_alfa wikiPageRevisionID "612476725".
- Moroctocog_alfa wikiPageWikiLink Antihemophilic_factor.
- Moroctocog_alfa wikiPageWikiLink Atomic_mass_unit.
- Moroctocog_alfa wikiPageWikiLink Category:Recombinant_proteins.
- Moroctocog_alfa wikiPageWikiLink Chinese_hamster_ovary.
- Moroctocog_alfa wikiPageWikiLink Chinese_hamster_ovary_cell.
- Moroctocog_alfa wikiPageWikiLink Factor_VIII.
- Moroctocog_alfa wikiPageWikiLink Genetics_Institute,_Inc..
- Moroctocog_alfa wikiPageWikiLink Glycoprotein.
- Moroctocog_alfa wikiPageWikiLink Haemophilia_A.
- Moroctocog_alfa wikiPageWikiLink Hemophilia_A.
- Moroctocog_alfa wikiPageWikiLink KDa.
- Moroctocog_alfa wikiPageWikiLink Post-translational_modification.
- Moroctocog_alfa wikiPageWikiLink Posttranslational_modification.
- Moroctocog_alfa wikiPageWikiLink Von_Willebrand_disease.
- Moroctocog_alfa wikiPageWikiLink Von_Willebrand_factor.
- Moroctocog_alfa wikiPageWikiLink Von_Willebrands_disease.
- Moroctocog_alfa wikiPageWikiLinkText "Moroctocog alfa".
- Moroctocog_alfa wikiPageWikiLinkText "moroctocog alfa".
- Moroctocog_alfa atcPrefix "B02".
- Moroctocog_alfa atcSuffix "BD02".
- Moroctocog_alfa chemspiderid "NA".
- Moroctocog_alfa hasPhotoCollection Moroctocog_alfa.
- Moroctocog_alfa legalStatus "Rx-only".
- Moroctocog_alfa molecularWeight "170".
- Moroctocog_alfa tradename "ReFacto".
- Moroctocog_alfa wikiPageUsesTemplate Template:Antihemorrhagics.
- Moroctocog_alfa wikiPageUsesTemplate Template:Blood-drug-stub.
- Moroctocog_alfa wikiPageUsesTemplate Template:Infobox_drug.
- Moroctocog_alfa wikiPageUsesTemplate Template:Reflist.
- Moroctocog_alfa subject Category:Recombinant_proteins.
- Moroctocog_alfa hypernym Factor.
- Moroctocog_alfa type ChemicalSubstance.
- Moroctocog_alfa type Drug.
- Moroctocog_alfa type Protein.
- Moroctocog_alfa type Drug.
- Moroctocog_alfa type Product.
- Moroctocog_alfa type ChemicalObject.
- Moroctocog_alfa type Thing.
- Moroctocog_alfa type Q8386.
- Moroctocog_alfa comment "Moroctocog alfa (trade name ReFacto) is a recombinant antihemophilic factor genetically engineered from Chinese hamster ovary (CHO) cell line. Chemically it is a glycoprotein. It is manufactured by Genetics Institute, Inc. and used to control and prevent hemorrhagic bleeding and prophylaxis associated with surgery or to reduce the number of spontaneous bleeding episodes in patients with hemophilia A.".
- Moroctocog_alfa label "Moroctocog alfa".
- Moroctocog_alfa sameAs m.0bbw5yt.
- Moroctocog_alfa sameAs Q6913198.
- Moroctocog_alfa sameAs Q6913198.
- Moroctocog_alfa wasDerivedFrom Moroctocog_alfa?oldid=612476725.
- Moroctocog_alfa isPrimaryTopicOf Moroctocog_alfa.